Anita Wolfer
4PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 18, 2025
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study.Susana Banerjee, Eleonora Ghisoni, Anita Wolfer
|Jan 23, 2025
[Oncology. Antibody-drug conjugates : a challenging innovation].Rita S Brito, Timothée Olivier, Anita Wolfer
|Sep 21, 2023
Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory Approval of (Neo)Adjuvant Cancer Treatment? The Swissmedic Perspective.Matea Pavic, Anita Wolfer, Qiyu Li
|Jul 06, 2023
A decade comparison of regulatory decision patterns for oncology products to all other non-oncology products among Swissmedic, European Medicines Agency, and US Food and Drug Administration.Ulrich-P Rohr, Mario Iovino, Leonie Rudofsky
Pageof 1
Frequent Collaborators
1 joint publications
Matea Pavic
1 joint publications
Andreas Wicki
1 joint publications
Timothée Olivier
1 joint publications
Susana Banerjee
1 joint publications
Eleonora Ghisoni
1 joint publications
Petronella Beatrix Ottevanger
1 joint publications
Ronan Le Scodan
1 joint publications
Apostolos Sarivalasis
1 joint publications
Ana Montes
1 joint publications
Judith Kroep
